1. |
PRRG2 |
ENSG00000126460 |
16 |
2 |
1.000 |
1.000 |
proline rich and Gla domain 2 [Source:HGNC Symbol;Acc:HGNC:9470] |
2. |
KRT20 |
ENSG00000171431, ENSG00000263057 |
2 |
0.85 |
0.850 |
- |
keratin 20 [Source:HGNC Symbol;Acc:HGNC:20412] |
3. |
BARX2 |
ENSG00000043039 |
27 |
0.85 |
0.850 |
- |
BARX homeobox 2 [Source:HGNC Symbol;Acc:HGNC:956] |
4. |
SNORA6 |
ENSG00000206760 |
7 |
0.85 |
0.850 |
- |
small nucleolar RNA, H/ACA box 6 [Source:HGNC Symbol;Acc:HGNC:32591] |
5. |
CD3E |
ENSG00000198851 |
2 |
0.85 |
0.850 |
- |
CD3e molecule [Source:HGNC Symbol;Acc:HGNC:1674] |
6. |
C9orf129 |
ENSG00000204352 |
3 |
0.85 |
0.850 |
- |
chromosome 9 open reading frame 129 [Source:HGNC Symbol;Acc:HGNC:31116] |
7. |
LOC101060542 |
|
3 |
0.85 |
0.850 |
- |
uncharacterized LOC101060542 |
8. |
PKD1L1 |
ENSG00000158683 |
9 |
0.85 |
0.850 |
- |
polycystin 1 like 1, transient receptor potential channel interacting [Source:HGNC Symbol;Acc:HGNC:18053] |
9. |
PAQR9-AS1 |
ENSG00000241570 |
2 |
0.85 |
0.850 |
- |
PAQR9 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:50861] |
10. |
VCX3B |
ENSG00000205642 |
11 |
0.85 |
0.850 |
- |
variable charge X-linked 3B [Source:HGNC Symbol;Acc:HGNC:31838] |
11. |
CIITA |
ENSG00000179583 |
4 |
0.763 |
- |
0.763 |
class II major histocompatibility complex transactivator [Source:HGNC Symbol;Acc:HGNC:7067] |
12. |
RBMY2FP |
ENSG00000243040 |
6 |
0.763 |
- |
0.763 |
RNA binding motif protein, Y-linked, family 2, member F pseudogene [Source:HGNC Symbol;Acc:HGNC:23891] |
13. |
OIT3 |
ENSG00000138315 |
41 |
0.757 |
- |
0.757 |
oncoprotein induced transcript 3 [Source:HGNC Symbol;Acc:HGNC:29953] |
14. |
PATE1 |
ENSG00000171053 |
2 |
0.755 |
- |
0.755 |
prostate and testis expressed 1 [Source:HGNC Symbol;Acc:HGNC:24664] |
15. |
ADAM29 |
ENSG00000168594 |
1 |
0.755 |
- |
0.755 |
ADAM metallopeptidase domain 29 [Source:HGNC Symbol;Acc:HGNC:207] |
16. |
MLIP-IT1 |
ENSG00000236996 |
2 |
0.755 |
- |
0.755 |
MLIP intronic transcript 1 [Source:HGNC Symbol;Acc:HGNC:41461] |
17. |
PROP1 |
ENSG00000175325, ENSG00000274382, ENSG00000280635 |
1 |
0.755 |
- |
0.755 |
PROP paired-like homeobox 1 [Source:HGNC Symbol;Acc:HGNC:9455] |
18. |
HOTS |
|
2 |
0.755 |
- |
0.755 |
H19 opposite tumor suppressor |
19. |
FCRL5 |
ENSG00000143297 |
1 |
0.755 |
- |
0.755 |
Fc receptor like 5 [Source:HGNC Symbol;Acc:HGNC:18508] |
20. |
FOXH1 |
ENSG00000160973 |
2 |
0.755 |
- |
0.755 |
forkhead box H1 [Source:HGNC Symbol;Acc:HGNC:3814] |
21. |
CELF2-AS2 |
ENSG00000237986 |
1 |
0.755 |
- |
0.755 |
CELF2 antisense RNA 2 [Source:HGNC Symbol;Acc:HGNC:44703] |
22. |
CYP8B1 |
ENSG00000180432 |
2 |
0.755 |
- |
0.755 |
cytochrome P450 family 8 subfamily B member 1 [Source:HGNC Symbol;Acc:HGNC:2653] |
23. |
SLC26A9 |
ENSG00000174502 |
8 |
0.755 |
- |
0.755 |
solute carrier family 26 member 9 [Source:HGNC Symbol;Acc:HGNC:14469] |
24. |
PROL1 |
PROL1 |
1 |
0.755 |
- |
0.755 |
|
25. |
POM121L2 |
ENSG00000158553 |
3 |
0.755 |
- |
0.755 |
POM121 transmembrane nucleoporin like 2 [Source:HGNC Symbol;Acc:HGNC:13973] |
26. |
LOC100130849 |
|
1 |
0.755 |
- |
0.755 |
phosphorylase kinase gamma subunit 1 pseudogene |
27. |
FLJ40288 |
ENSG00000183470 |
4 |
0.755 |
- |
0.755 |
uncharacterized FLJ40288 [Source:NCBI gene;Acc:286023] |
28. |
LOC101927919 |
|
3 |
0.755 |
- |
0.755 |
uncharacterized LOC101927919 |
29. |
CAPNS2 |
ENSG00000256812 |
2 |
0.755 |
- |
0.755 |
calpain small subunit 2 [Source:HGNC Symbol;Acc:HGNC:16371] |
30. |
SLC5A11 |
ENSG00000158865 |
1 |
0.755 |
- |
0.755 |
solute carrier family 5 member 11 [Source:HGNC Symbol;Acc:HGNC:23091] |
31. |
FAM99A |
ENSG00000205866, ENSG00000281261, ENSG00000281733 |
1 |
0.755 |
- |
0.755 |
family with sequence similarity 99 member A [Source:HGNC Symbol;Acc:HGNC:32368] |
32. |
FAM9C |
ENSG00000187268 |
3 |
0.752 |
- |
0.752 |
family with sequence similarity 9 member C [Source:HGNC Symbol;Acc:HGNC:18405] |
33. |
INHBC |
ENSG00000175189 |
2 |
0.744 |
- |
0.744 |
inhibin subunit beta C [Source:HGNC Symbol;Acc:HGNC:6068] |
34. |
MASP2 |
ENSG00000009724 |
4 |
0.736 |
- |
0.736 |
mannan binding lectin serine peptidase 2 [Source:HGNC Symbol;Acc:HGNC:6902] |
35. |
LOC101927755 |
|
58 |
0.736 |
0.736 |
- |
uncharacterized LOC101927755, transcript variant 2 |
36. |
CCL19 |
ENSG00000172724 |
1 |
0.735 |
- |
0.735 |
C-C motif chemokine ligand 19 [Source:HGNC Symbol;Acc:HGNC:10617] |
37. |
LSAMP-AS1 |
ENSG00000240922 |
2 |
0.732 |
- |
0.732 |
LSAMP antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:40350] |
38. |
BEST1 |
ENSG00000167995 |
3 |
0.73 |
- |
0.730 |
bestrophin 1 [Source:HGNC Symbol;Acc:HGNC:12703] |
39. |
TMED6 |
ENSG00000157315 |
9 |
0.719 |
- |
0.719 |
transmembrane p24 trafficking protein 6 [Source:HGNC Symbol;Acc:HGNC:28331] |
40. |
STAG3L3 |
ENSG00000174353 |
36 |
0.715 |
0.715 |
- |
stromal antigen 3-like 3 (pseudogene) [Source:HGNC Symbol;Acc:HGNC:33845] |
41. |
LINC01179 |
ENSG00000249500 |
9 |
0.715 |
- |
0.715 |
long intergenic non-protein coding RNA 1179 [Source:HGNC Symbol;Acc:HGNC:49556] |
42. |
IRGM |
ENSG00000237693 |
1 |
0.715 |
- |
0.715 |
immunity related GTPase M [Source:HGNC Symbol;Acc:HGNC:29597] |
43. |
POU3F4 |
ENSG00000196767 |
9 |
0.707 |
0.707 |
- |
POU class 3 homeobox 4 [Source:HGNC Symbol;Acc:HGNC:9217] |
44. |
BPIFB2 |
ENSG00000078898 |
3 |
0.705 |
- |
0.705 |
BPI fold containing family B member 2 [Source:HGNC Symbol;Acc:HGNC:16177] |
45. |
PRR5-ARHGAP8 |
ENSG00000248405 |
2 |
0.703 |
- |
0.703 |
PRR5-ARHGAP8 readthrough [Source:HGNC Symbol;Acc:HGNC:34512] |
46. |
LOC100507351 |
|
25 |
0.702 |
- |
0.702 |
uncharacterized LOC100507351 |
47. |
HLA-J |
ENSG00000204622, ENSG00000223439, ENSG00000226586, ENSG00000228220, ENSG00000228524, ENSG00000234074, ENSG00000235309, ENSG00000243336 |
3 |
0.701 |
0.701 |
- |
major histocompatibility complex, class I, J (pseudogene) [Source:HGNC Symbol;Acc:HGNC:4967] |
48. |
GPR39 |
ENSG00000183840 |
5 |
0.701 |
- |
0.701 |
G protein-coupled receptor 39 [Source:HGNC Symbol;Acc:HGNC:4496] |
49. |
EPHA1 |
ENSG00000146904, ENSG00000284816 |
6 |
0.701 |
- |
0.701 |
EPH receptor A1 [Source:HGNC Symbol;Acc:HGNC:3385] |